Dexrazoxane May Preserve Left Ventricular Function in Cancer Survivors Edited by Katie Lennon

https://www.medscape.com/viewarticle/dexrazoxane-may-preserve-left-ventricular-function-cancer-2026a1000rvy?src= Dexrazoxane was associated with preserved left ventricular (LV) systolic function in childhood cancer survivors treated with doxorubicin in a new analysis. Among 895 patients, those receiving dexrazoxane showed better LV fractional shortening and reduced incidence of LV dysfunction, particularly in high-risk groups where rates approached those of moderate-risk patients.